NeuroOne wins NASDAQ list – MassDevice
NeuroOne Medical Technologies (OTC: NMTC) announced that it has been approved to uplist and start trading on the Nasdaq market.
According to a press release, Eden Prairie, Minnesota-based NeuroOne expects trading to begin today when the market opens, with the company trading under the symbol “NMTC.”
The developer of surgical care options for patients with neurological disorders will continue to trade on the OTC markets until trading begins on the Nasdaq.
“The NeuroOne team has worked tirelessly over the past four years to position the company to accomplish this major milestone,” said Dave Rosa, CEO of NeuroOne, in the statement. “The Nasdaq has an established reputation as an exchange associated with emerging growth stocks and we believe our listing will raise the profile of the company with current and potential investors, and the financial community at large.
“As the company continues to grow, we hope that our Nasdaq location will generate even greater interest in our company from leading institutional investment firms across the national investment community. and international. I would also like to thank all of our current and past investors who have played a vital role in helping us take this crucial step. “